Market,Report,Tumor,Ablation,S business, insurance Market Report - Tumor Ablation Market Size, Company Share To

As we all know to live in this world we have to perform some activity by which we can earn money. There are many activities by which we can earn money and meet the standards to live in this society. And from one of them is franchise.  Franc Small offices have unique needs, and thatincludes document shredding. Designed with the smaller business inmind, the Dahle 20314 is a cross-cut shredder that offers Level 3security and brings you into compliance with federal regulations. The

Global tumor ablation market is expected to reach USD 1.5 billion by 2022, according to a new study by Grand View Research Inc. Rising prevalence of different forms of cancer and increasing technological advancements in the field of thermal ablation techniques are the most prominent drivers of the market. Besides the use of thermal ablation, techniques such as laser ablation, irreversible electroporation, High Intensity Focused Ultrasonography (HIFU) are also clinically growing, concurrently propelling the tumor ablation industry. Occurrence of lung, breast, and liver cancer is on the rise globally. According to the Center for Disease Control (CDC) and other organizations, currently, about 210,828 cases of lung cancer, 2.9 million cases of breast cancer, and over 2.7 million cases of prostate cancer are reported in the U.S. alone. In terms of technological advancement, companies such as SonaCare Medical are coupling ablation techniques with other technologies to improve accuracy, performance, and level of care. SonaLink, a remote patient monitoring platform, was put to use along with Sonatherm ablation system to enable physicians to enhance patient care experience, thereby promoting market growth. The industry is also anticipated to witness mergers and joint collaborations as a tool to curb rising competition. For instance, Boston Scientific Corporation acquired C.R. Bard Electrophysiology, which led to a 48.0% hike in profit for the former company.Browse full research report on Global Tumor Ablation Market: http://www.grandviewresearch.com/industry-analysis/tumor-ablation-marketFurther key findings from the study suggest:Microwave ablation technology is expected to be the fastest growing segment over the forecast period at a CAGR of over 15.0%. Reduction in the procedure time and low cost for treatment are some of the attributes favoring growth.In terms of treatment, surgical ablation is predicted to form the largest market by 2022 with about 35.0% share. Liver and lung cancer ablation require surgical procedures, and since these form the largest and fastest growing segments, they concomitantly propel surgical ablation growth.Lung cancer forms the most lucrative market and is anticipated to be the fastest growing segment over the forecast period. By 2022, it is expected to contribute about 15.0% of the revenue share owing to its rising prevalence rate across the globe.According to market forecast for 2022, North America is expected to dominate the market and Asia Pacific is anticipated to witness the fastest growth. Augmenting growth in the cancer prevalence and rising healthcare expenditure in regions such as China, Korea, and India are factors responsible for this rapid growth.Major players of the market include HealthTronics, Galil Medical Inc., Angiodynamics, Medtronic Plc. (Covidien), Boston Scientific Corporation, SonaCare Medical, Misonix Inc., EDAP TMS S.A., and Neuwave Medical Inc. To retain market leadership, players such as Medtronic are working towards acquiring other companies and expanding their portfolio. For instance, in January 2016, Medtronic acquired the OsteoCool RF Ablation System from Baylis Medical. Read detailed report or request for sample of this research report:  http://www.grandviewresearch.com/industry-analysis/tumor-ablation-market/requestGrand View Research has segmented the global tumor ablation market on the basis of technology, treatment, application, and region Global Tumor Ablation Technology Outlook (USD million), 2012 – 2022RadiofrequencyMicrowave ablationCryoablationOther ablation technologiesGlobal Tumor Ablation Treatment Outlook (USD million), 2012 – 2022Surgical tumor ablationLaparoscopic tumor ablationPercutaneous tumor ablationGlobal Tumor Ablation Application Outlook (USD million), 2012 – 2022Liver cancerBreast cancerLung cancerProstate cancerOther cancersTumor Ablation Region Outlook (USD million), 2012 – 2022North AmericaU.S.U.S. tumor ablation market technology outlookRadiofrequencyMicrowave ablationCryoablationOther ablation technologiesU.S. tumor ablation market treatment outlookSurgical tumor ablationLaparoscopic tumor ablationPercutaneousU.S. tumor ablation market application outlookLiver cancerBreast cancerLung cancerProstate cancerOther cancerCanadaCanada tumor ablation market technology outlookRadiofrequencyMicrowave ablationCryoablationOther ablation technologiesCanada tumor ablation market treatment outlookSurgical tumor ablationLaparoscopic tumor ablationPercutaneousCanada tumor ablation market application outlookLiver cancerBreast cancerLung cancerProstate cancerOther cancerEuropeUKUK tumor ablation market technology outlookRadiofrequencyMicrowave ablationCryoablationOther ablation technologiesUK tumor ablation market treatment outlookSurgical tumor ablationLaparoscopic tumor ablationPercutaneousUK tumor ablation market application outlookLiver cancerBreast cancerLung cancerProstate cancerOther cancerGermanyGermany tumor ablation market technology outlookRadiofrequencyMicrowave ablationCryoablationOther ablation technologiesGermany tumor ablation market treatment outlookSurgical tumor ablationLaparoscopic tumor ablationPercutaneousGermany tumor ablation market application outlookLiver cancerBreast cancerLung cancerProstate cancerOther cancerAsia PacificJapanJapan tumor ablation market technology outlookRadiofrequencyMicrowave ablationCryoablationOther ablation technologiesJapan tumor ablation market treatment outlookSurgical tumor ablationLaparoscopic tumor ablationPercutaneousJapan tumor ablation market application outlookLiver cancerBreast cancerLung cancerProstate cancerOther cancerChinaChina tumor ablation market technology outlookRadiofrequencyMicrowave ablationCryoablationOther ablation technologiesChina tumor ablation market treatment outlookSurgical tumor ablationLaparoscopic tumor ablationPercutaneousChina tumor ablation market application outlookLiver cancerBreast cancerLung cancerProstate cancerOther cancerLatin AmericaBrazilBrazil tumor ablation market technology outlookRadiofrequencyMicrowave ablationCryoablationOther ablation technologiesBrazil tumor ablation market treatment outlookSurgical tumor ablationLaparoscopic tumor ablationPercutaneousBrazil tumor ablation market application outlookLiver cancerBreast cancerLung cancerProstate cancerOther cancerMexicoMexico tumor ablation market technology outlookRadiofrequencyMicrowave ablationCryoablationOther ablation technologiesMexico tumor ablation market treatment outlookSurgical tumor ablationLaparoscopic tumor ablationPercutaneousMexico tumor ablation market application outlookLiver cancerBreast cancerLung cancerProstate cancerOther cancerMEASouth AfricaSouth Africa tumor ablation market technology outlookRadiofrequencyMicrowave ablationCryoablationOther ablation technologiesSouth Africa tumor ablation market treatment outlookSurgical tumor ablationLaparoscopic tumor ablationPercutaneousSouth Africa tumor ablation market application outlookLiver cancerBreast cancerLung cancerProstate cancerOther cancerSaudi ArabiaSaudi Arabia tumor ablation market technology outlookRadiofrequencyMicrowave ablationCryoablationOther ablation technologiesSaudi Arabia tumor ablation market treatment outlookSurgical tumor ablationLaparoscopic tumor ablationPercutaneousSaudi Arabia tumor ablation market application outlookLiver cancerBreast cancerLung cancerProstate cancerOther cancerBrowse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices